Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
Harbin Pharma Agrees to Acquire Clinical Approval for Jesduvroq from Bocimed
June 3, 2025
Company
Drug
Zelgen Biopharmaceuticals Presents Clinical Updates for Alveltamig, Nilvanstomig and ZGGS15 at ASCO 2025
June 3, 2025
Company
Drug
Alphamab Oncology Presents JSKN003 Clinical Data at 2025 ASCO Annual Meeting
June 3, 2025
Company
Drug
Hengrui Pharmaceuticals Gains NMPA Approval for HRS9531 Clinical Study in Type 2 Diabetes
June 3, 2025
Company
Drug
Huadong Medicine Files for NMPA Approval of Ranibizumab Biosimilar
June 3, 2025
Company
Deals
Hansoh Pharmaceutical Partners with Regeneron for HS-20094 Global Rights
June 3, 2025
Company
Drug
CSPC Pharmaceutical’s JMT101 Receives Breakthrough Therapy Designation for Colorectal Cancer
June 3, 2025
Company
Drug
Zai Lab Presents ZL-1310 Clinical Results for Small Cell Lung Cancer at ASCO
June 3, 2025
Company
Drug
Alphamab Oncology Presents JSKN003 Clinical Data at 2025 ASCO Annual Meeting
June 3, 2025
Company
Drug
Innovent Biologics Presents IBI363 Clinical Results at 2025 ASCO Annual Meeting
June 3, 2025
Company
Drug
BeOne Medicines Wins Conditional Approval for Ziihera in HER2-Positive BTC
June 3, 2025
Company
Deals
LongBio Pharma Secures RMB 200 Million Series C Funding for Clinical Studies
June 3, 2025
1
2
…
25
26
27
28
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
